Business  
/
 
Sectors  
/
 
Health & Pharma

AbbVie sues medicines regulator

Mon, Mar 11, 2013, 09:29

First published: Mon, Mar 11, 2013, 00:00

   

A leading US pharmaceutical group has sued Europe's medicines regulator, in a sharp intensification of the battle between advocates for greater transparency on drugs and companies who fear their competitive position will be undermined by more openness.

AbbVie, formerly part of Abbott, has sought an injunction to block the European Medicines Agency from releasing detailed data on the effects in individual patients in clinical trials of its top-selling medicine Humira for rheumatoid arthritis.

– Copyright The Financial Times Limited 2013

Mon, Mar 11, 2013, 09:29

First published: Mon, Mar 11, 2013, 00:00

   

Health Pharma

Regulators have fined nine drugmakers, including Denmark’s Lundbeck, a total of €146 million for blocking the supply of a cheaper anti-depressant to the market Punishments follow 2009 report by European Commission on pharmaceutical sector
Japanese prime minister Shinzo Abe visits Titanic Belfast with First Minister Peter Robinson and deputy First Minister Martin McGuinness yesterday. Photograph: Kelvin Boyes/Press Eye/PA Wire Japanese firm to create over 400 jobs in Antrim
Royalty Pharma co-founder and chairman Rory Biggs. The US-based company has withdrawn its hostile bid for Irish drugmaker Elan. Royalty Pharma drops hostile bid for Elan